uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 08, 2020

FDA Warns Seller of Opioid Withdrawal Supplement

On August 25, 2020, the FDA issued a warning letter to Renewal Supplements LLC following a review of the company's website, which found statements made about the company product Opi-Cure to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at